Quoting from the announcement!
Cellmids reliable and reproducible MK ELISA is essential for the validation of cancer
diagnostic and prognostic applications. It will also enable the wider scientific
community engaged in midkine research to confidently generate data for
diagnostic and therapeutic applications.
IMHO That alone is exciting news!
- Forums
- ASX - By Stock
- AN1
- cancer diagnosis
cancer diagnosis, page-20
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable